Journal article
1758PD Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG)
Abstract
Background CMs are products used concurrently with conventional medicine, including natural products and homeopathy. CM use is prevalent amongst cancer patients, but the use in patients enrolled on P3T had yet to be studied. This study examined patient characteristics and outcomes of CM users enrolled in P3T conducted by the CCTG. Methods Data were acquired from six international P3T and included patients with metastatic breast (BR), colorectal …
Authors
Wells JC; Sidhu A; Ding K; Heng DYC; Shepherd F; Ellis PM; Bradbury PA; Jonker DJ; Moore M; Siu LL
Journal
Annals of Oncology, Vol. 30, ,
Publisher
Elsevier
Publication Date
October 2019
DOI
10.1093/annonc/mdz265.005
ISSN
0923-7534